Skip to main content

Table 1 Levels of blood GSH (mg/L) and hepatic GSH (mg/g) and activities of blood & hepatic GPx and SOD (U/mg) in various animal groups

From: Investigation into the antioxidant role of arginine in the treatment and the protection for intralipid-induced non-alcoholic steatohepatitis

Group

Control

IL

Arg

IL + Arg

Arg + IL

Parameter

Blood GSH

24.8 ± 0.7‡,§,¶,II

15.7 ± 0.8†,§,¶,II

41.6 ± 0.9†,‡,¶,II

34 ± 0.9†, ‡, §

33.4 ± 1.6†, ‡, §

Hepatic GSH

0.15 ± 0.001‡,§,¶

0.08 ± 0.01†,§,¶,II

0.2 ± 0.01†,‡,¶,II

0.19 ± 0.01†,‡,§,II

0.16 ± 0.01‡,§, ¶

Blood GPx

1.2 ± 0.01‡,§,¶,II

0.77 ± 0.03†,§,¶,II

1.3 ± 0.02†,‡

1.33 ± 0.02†,‡,II

1.27 ± 0.01†, ‡,¶

Hepatic GPx

3.6 ± 0.15‡,§,¶,II

2.9 ± 0.07†,§,¶,II

5.5 ± 0.19†,‡,II

5.44 ± 0.14†,‡,II

4.8 ± 0.14†, ‡, §,¶

Blood SOD

1.23 ± 0.04‡,§

1.1 ± 0.0†,§,¶,II

1.34 ± 0.0†,‡

1.33 ± 0.04

1.25 ± 0.04

Hepatic SOD

2.9 ± 0.07§,¶,II

2.6 ± 0.16§,¶,II

3.63 ± 0.09†,‡

3.62 ± 0.9†,‡

3.45 ± 0.1†,‡

  1. All values are expressed as the mean ± SEM and compared with: † control group; ‡ IL-treated group; § Arg-treated group; ¶ IL + Arg-treated group; II Arg + IL-treated group. Significance (p < 0.05)